This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Counterfeit drugs take center stage in USTR's 2024 Notorious Markets List

( January 8, 2025, 10:10 GMT | Official Statement) -- MLex Summary: The Office of the US Trade Representative released its 2024 Review of Notorious Markets, focusing its analysis this year on the proliferation of illicit online pharmacies peddling fake drugs. In all, the report singles out 38 online markets and 33 physical markets as rife with counterfeiting and piracy, while also drawing attention to successful intellectual property enforcement campaigns in Kuwait, Vietnam and more.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections